Philip Liang - Dec 31, 2022 Form 4 Insider Report for Vicarious Surgical Inc. (RBOT)

Role
Director
Signature
/s/ June Morris, Attorney-in-Fact
Stock symbol
RBOT
Transactions as of
Dec 31, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 03:31 PM
Previous filing
Nov 14, 2022
Next filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RBOT Class A Common Stock Award +6.21K +0.52% 1.19M Dec 31, 2022 Direct F1
holding RBOT Class A Common Stock 43.9K Dec 31, 2022 By Chelvey International Limited F2
holding RBOT Class A Common Stock 330K Dec 31, 2022 By E15 Fund Advisors (HK) Limited F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $12,537.50 of cash retainer fees earned during the fourth quarter of 2022. The RSUs were fully vested on the grant date.
F2 Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.
F3 Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein.